NEW YORK(GenomeWeb) – OncoDNA announced on Wednesday that it has finalized a South Korean distribution agreement with Eone-Diagnomics Genome Center (EDGC).

Under the terms of the agreement, EDGC will have exclusive distribution rights in South Korea for the OncoDEEP Dx panel and other cancer-related tests. Korean physicians will have access to clinically relevant interpretations of test results using the OncoShare web platform.

The OncoDEEP Dx is a 50-gene next-generation sequencing-based diagnostic test that runs on Life Technologies' Ion Torrent instrument.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.